Wendi Mason, MSN presents Adherence to Treatment Plans: Safety and Management of Side Effects with Pirfenidone and Nintedanib during the Diagnosis and Treatment of Comorbidities and Approved Therapies for IPF session of the PFF Summit 2017.
Please note that any information contained in this presentation is for informational and/or educational purposes only. This is not an endorsement of any specific service or medication. It is not intended to be a substitute for professional medical advice. Always consult your personal physician or health care provider with any questions you may have regarding your specific medical condition. If you desire or need advice or referral information, please consult your health care provider or contact the PFF Patient Communication Center (PCC). (Toll Free) 844-Talk-PFF or pcc@pulmonaryfibrosis.org.
Opening Music: www.bensound.com
4 окт 2024
